Cargando…
Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer
Autores principales: | Gee, Julia MW, Giles, Martin G, Nicholson, Robert I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC468673/ https://www.ncbi.nlm.nih.gov/pubmed/15217488 http://dx.doi.org/10.1186/bcr904 |
Ejemplares similares
-
Complementary yet distinct roles for oestrogen receptor-α and oestrogen receptor-β in mouse mammary epithelial proliferation
por: Clarke, Robert B
Publicado: (2004) -
Chaperone-mediated destruction of erbB2: relevance to tyrosine kinase inhibitors
por: Gee, Julia MW
Publicado: (2002) -
Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models
por: Gee, Julia MW, et al.
Publicado: (2005) -
ADAM metalloproteases and EGFR signalling
por: Gee, Julia MW, et al.
Publicado: (2003) -
Live or let die: oestrogen regulation of survival signalling in endocrine response
por: Butt, Alison J, et al.
Publicado: (2007)